Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound

Oncogene

Volumn 14, Issue 4, 1997, Pages 385-393

  Sun, Yi ^a   Bian, Junhui ^a   Wang, Yuli ^a   Jacobs, Christine ^a  

^a PFIZER INC   (United States)

Author keywords

Apoptosis; p53; Phenanthroline; Redox regulation; Transcriptional activation

Indexed keywords

1,10 PHENANTHROLINE; CHELATING AGENT; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL; CELL DEATH; CELL FREE SYSTEM; HUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR CELL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

MURINAE;

EID: 0031025644     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200834     Document Type: Article

References (55)

1. Abello PA, Fidler SA, Bulkley GB and Buchman TG. (1994). Arch. Surg., 129, 134-141.
2. Adebodun F and Post JF. (1995). J. Cell. Physiol., 163, 80-86.
3. Almendral JM, Huebsch D, Blundell PA, Macdonald-Bravo H and Bravo R. (1987). Proc. Natl. Acad. Sci. USA, 84, 1575-1579.
4. Atadja P, Wong H, Garkavtsev I, Veillette C and Riabowol K. (1995). Proc. Natl. Acad. Sci. USA, 92, 8348-8352.
5. Auld DS. (1988). JF Riordan and BL Vallce (eds.) Methods in Enzymology vol. 158, Metallobiochemistry, Part A. pp. 110- 114, Academic Press: New York.
6. Baker SJ, Markowitz S, Fearon ER, Willson JK and Vogelstein B. (1990). Science, 249, 912-915.
7. Bessho R, Matsubara K, Kubota M, Kuwakado K, Hirota H, Wakazono Y, Lin YW, Okada A, Kawai M and Nishikomori R. (1994). Biochem. Pharmacol., 48, 1883-1889.
8. Butcher S, Hainaut P and Milner J. (1994). Biochem. J., 298, 513-516.
9. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
10. El-Deiry WS, Kern S, Pietenpol JA, Kinzler KW and Vogelstein B. (1992). Nature Genet., 1, 45-49.
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
12. Fry DW, Boritzki TJ, Besserer JA and Jackson RC. (1985). Biochem. Pharmacol., 34, 3499-3508.
13. Haffner R and Oren M. (1995). Current Opinion Genet. Dev., 5, 84-90.
14. Hainaut P, Butcher S and Milner J. (1995a). Br. J. Cancer, 71, 227-231.
15. Hainaut P and Milner J. (1993a). Cancer Res., 53, 4469-4473.
16. Hainaut P and Milner J. (1993b). Cancer Res., 53, 1739-1742.
17. Hainaut P, Rolley N, Davies M and Milner J. (1995b). Oncogene, 10, 27-32.
18. Halliwell B and Gutteridge JMC. (1989). Free Radicals in Biology and Medicine, 2nd edn. Clarendon Press: Oxford.
19. Hartwell L. (1992). Cell, 71, 543-546.
20. Hughes FM Jr and Cidlowski JA. (1994). J. Steroid. Biochem. Mol. Biol., 49, 303-310.
21. Hupp TR, Meek DW, Midgley CA and Lane DP. (1993). Nucleic Acids Res., 21, 3167-3174.
22. Juven T, Barak Y, Zauberman A, George DL and Oren M. (1993). Oncogene, 8, 3411-3416.
23. Kastan MB, Canman CE and Leonard CJ. (1995). Cancer Metast. Rev., 14, 3-15.
24. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
25. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ Jr. (1992). Cell, 71, 587-597.
26. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B. (1991). Science, 252, 1708-1711.
27. Kernohan NM, Hupp TR and Lane DP. (1996). J. Biol. Chem., 271, 4954-4960.
28. Ko LJ and Prives C. (1996). Genes & Develop., 10, 1054-1072.
29. Lane DP. (1994). Brit. Med. Bull., 50, 582-599.
30. Liebermann DA, Hoffman B and Steinman RA. (1995). Oncogene, 11, 199-210.
31. Lowe SW, Ruly HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
32. Mariani SM, Matiba B, Baumler C and Krammer PH. (1995). Eur. J. Immunol., 25, 2303-2307.
33. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
34. Morris GF, Bischoff JR and Mathews MB. (1996). Proc. Natl. Acad. Sci. USA, 93, 895-899.
35. Oltvai ZN, Milliamn CL and Korsmeyer SJ. (1993). Cell, 74, 609-619.
36. Papathanasiou MA, Kerr NK, Robbins JH, McBride OW, Alamo I, Barrett SF, Hickson ID and Fornace AJ. (1991). Mol. Cell. Biol., 11, 1009-1016.
37. Pavletich NP, Chambers KA and Pabo CO. (1993). Genes Dev., 7, 2556-2564.
38. Rainwater R, Parks D, Anderson ME, Tegtmeyer P and Mann K. (1995). Mol. Cell. Biol., 15, 3892-3903.
39. Sebolt JS, Scavone SV, Pinter CD, Hamelehle KL, Von Hoff DD and Jackson RC. (1987). Cancer Res., 47, 4299-4304.
40. Selivanova G and Wiman KG. (1995). Adv. Cancer Res., 66, 143-180.
41. Shivakumar CV, Brown DR, Deb S and Deb SP. (1995). Mol. Cell. Biol., 15, 6785-6793.
42. Srinivasan R, Roth JA and Maxwell SA. (1993). Cancer Res., 53, 5361-5364.
43. Sun Y. (1990). Free Rad. Biol. Med., 8, 583-599.
44. Sun Y, Dong Z, Jackman J, Hegamyer G, Kim H, Sithanandam K and Colburn N. (1995). Int. J. Oncol., 6, 465-471.
45. Sun Y, Dong Z, Nakamura K and Colburn NH. (1993a). FASEB J., 7, 944-950.
46. Sun Y, Hegamyer G, Nakamura K, Kim H, Oberley LW and Colburn NH. (1993b). Int. J. Cancer, 55, 952-956.
47. Sun Y, Nakamura K, Hegamyer GA, Dong Z and Colburn NH. (1993c). Mol. Carcinog., 8, 49-57.
48. Sun Y and Oberley LW. (1996). Free Rad. Biol. Med., 21, 335-348.
49. Sun Y, Pommier Y and Colburn NH. (1992). Cancer Res., 52, 1907-1915.
50. Tishler RB, Calderwood SK, Coleman CN and Price BD. (1993). Cancer Res., 53, 2212-2216.
51. Tishler RB, Lamppu DM, Park S and Price BD. (1995). Cancer Res., 55, 6021-6025.
52. Whitacre CM, Hashimoto H, Tsai ML, Chatterjee S, Berger SJ and Berger NA. (1995). Cancer Res., 55, 3697-3701.
53. Wu X, Bayle JH, Olson D and Levine AJ. (1993). Genes & Dev., 7, 1126-1132.
54. Zalewski PD, Forbes IJ and Giannakis C. (1991). Biochem. Int., 24, 1093-1101.
55. Zhan Q, Fan A, Bae I, Guillouf C, Liebermann DA, O'Connor PM and Fornace AJ Jr. (1994). Oncogene, 9, 3743-3751.